It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In the brain, AMPA receptors mediate fast excitatory neurotransmission, the dysfunction of which leads to neuropsychiatric disorders. Synaptic function of AMPA receptors is tightly controlled by a protein group called transmembrane AMPAR regulatory proteins (TARPs). TARP γ-8 (also known as CACNG8) preferentially expresses in the hippocampus, cortex and subcortical regions that are critical for emotion generation indicating its association with psychiatric disorders. Here, we identified rs10420324 (T/G), a SNP located in the human CACNG8 gene, regulated reporter gene expression in vitro and TARP γ-8 expression in the human brain. A guanine at the locus (rs10420324G) suppressed transcription likely through modulation of a local G-quadruplex DNA structure. Consistent with these observations, the frequency of rs10420324G was higher in patients with anti-social personality disorder (ASPD) than in controls, indicating that rs10420324G in CACNG8 is more voluntary for ASPD. We then characterized the behavior of TARP γ-8 knockout and heterozygous mice and found that consistent with ASPD patients who often exhibit impulsivity, aggression, risk taking, irresponsibility and callousness, a decreased γ-8 expression in mice displayed similar behaviors. Furthermore, we found that a decrease in TARP γ-8 expression impaired synaptic AMPAR functions in layer 2–3 pyramidal neurons of the prefrontal cortex, a brain region that inhibition leads to aggression, thus explaining, at least partially, the neuronal basis for the behavioral abnormality. Taken together, our study indicates that TARP γ-8 expression level is associated with ASPD, and that the TARP γ-8 knockout mouse is a valuable animal model for studying this psychiatric disease.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Nanjing University, MOE Key Laboratory of Model Animal for Disease Study, Department of Neurology, Drum Tower Hospital, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing University, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, National Resource Center for Mutant Mice, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
2 Nanjing Normal University, School of Psychology, Nanjing, China (GRID:grid.260474.3) (ISNI:0000 0001 0089 5711)
3 Nanjing University, MOE Key Laboratory of Model Animal for Disease Study, Department of Neurology, Drum Tower Hospital, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
4 Nanjing University, Reward, Competition and Social Neuroscience Lab, Department of Psychology, School of Social and Behavioral Sciences, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)
5 Chinese Brain Bank Center, Wuhan, China (GRID:grid.41156.37)
6 Shanghai Jiao Tong University School of Medicine, Shanghai Mental Health Center, Shanghai, China (GRID:grid.16821.3c) (ISNI:0000 0004 0368 8293)
7 Yale University School of Medicine, Division of Human Genetics, Department of Psychiatry, New Haven, USA (GRID:grid.47100.32) (ISNI:0000000419368710)
8 Nanjing Normal University, School of Psychology, Nanjing, China (GRID:grid.260474.3) (ISNI:0000 0001 0089 5711); Nanjing Medical University Affiliated Nanjing Brain Hospital, Department of Medical Psychology, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
9 First Affiliated Hospital of Zhengzhou University, Department of Anesthesiology and Perioperative Medicine, Zhengzhou, China (GRID:grid.412633.1)
10 Capital Medical University, School of Basic Medical Sciences, Beijing Key Laboratory of Neural Regeneration and Repair, Advanced Innovation Center for Human Brain Protection, Beijing, China (GRID:grid.24696.3f) (ISNI:0000 0004 0369 153X)
11 Nanjing Medical University Affiliated Nanjing Brain Hospital, Department of Medical Psychology, Nanjing, China (GRID:grid.89957.3a) (ISNI:0000 0000 9255 8984)
12 Nanjing University, MOE Key Laboratory of Model Animal for Disease Study, Department of Neurology, Drum Tower Hospital, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing University, State Key Laboratory of Pharmaceutical Biotechnology, Model Animal Research Center, National Resource Center for Mutant Mice, Medical School, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing University, Institute for Brain Sciences, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X); Nanjing University, Chemistry and Biomedicine Innovation Center, Nanjing, China (GRID:grid.41156.37) (ISNI:0000 0001 2314 964X)